The Easiest Standing Ovation in Washington
Bipartisan applause at a State of the Union address is almost always a tell. It means the president said something so broadly popular, so motherhood-and-apple-pie uncontroversial, that even the opposing party couldn't sit on their hands without looking like they support whatever the thing is being opposed. Anti-cartel rhetoric. Fentanyl crackdown. Nobody is going to stand up in that chamber and say they're against it.
Which is why the applause tells us almost nothing useful.
What matters — what has always mattered — is the gap between the rhetoric and the regulatory machinery that either implements it or quietly buries it. And on fentanyl, that gap has been cavernous for years, across administrations of both parties.
The CDC reported 107,500 drug overdose deaths in 2023. That number dropped slightly in 2024 — the first decline in five years — and the Trump administration has taken credit for it. Some of that credit is probably earned. Some of it reflects trends that were already in motion. The honest answer is that causation in public health data is genuinely complex and anyone who gives you a clean narrative is simplifying for political effect, including me right now.
What the Address Actually Proposed
Trump's State of the Union address framed the cartel and fentanyl crisis as fundamentally a border security and foreign policy problem. That framing is partially correct and partially self-serving.
It's correct that the majority of fentanyl entering the United States crosses at ports of entry — often in vehicles, often in small quantities that aggregate to enormous supply. It's correct that the cartels controlling this supply chain are sophisticated transnational criminal organizations that operate with a level of organizational complexity that rivals midsize corporations. The Sinaloa Cartel's logistics network would be studied in business schools if it were legal.
It's correct that previous administrations — Republican and Democrat — failed to treat cartel operations as the national security emergency they are. The reluctance to designate cartels as foreign terrorist organizations, the half-measures on financial sanctions, the diplomatic hesitancy around pressuring Mexico — these were real failures with real body counts.
Where the framing gets self-serving is in the implied solution: tighter border enforcement as the primary intervention. Border enforcement matters. It's not sufficient. Because fentanyl is not primarily a border story — it's a demand story, a manufacturing story, and a financial story that runs through American banks and Chinese chemical precursor suppliers and Mexican cartel accountants and American distributors and eventually terminates in American communities that have been economically hollowed out for thirty years.
The Regulatory Failure Nobody Clapped For
Nobody in that chamber applauded for what actually needs to happen, because what actually needs to happen is complicated and doesn't fit in a State of the Union soundbite.
The DEA's budget has been flat in real terms for a decade while cartel operations have grown dramatically in sophistication. The financial intelligence infrastructure that could track cartel money flows through American institutions is chronically underfunded and understaffed. The precursor chemical controls that would restrict Chinese suppliers from selling fentanyl-producing compounds to Mexican cartels require sustained diplomatic pressure and enforcement mechanisms that the Treasury and State Departments have never fully committed to.
I've worked with small healthcare providers in rural communities — places that have been absolutely devastated by the opioid epidemic and its fentanyl successor. The regulatory landscape they operate in is crushing: prior authorization requirements that delay addiction treatment by days or weeks, DEA registration burdens that make it harder for rural practitioners to prescribe buprenorphine, reimbursement structures that make running a small addiction medicine practice economically unsustainable.
So you have a crisis being created by products flowing through sophisticated criminal networks, and the treatment infrastructure is being strangled by regulations designed to prevent overprescription of a completely different category of drugs. The fentanyl killing people is not being prescribed by rural family doctors. But those doctors face compliance burdens designed as if it were.
Credit Where It's Due, Pressure Where It's Needed
Trump deserves credit for treating the cartel problem with the seriousness it warrants. The designation of major cartels as foreign terrorist organizations — something previous administrations avoided for diplomatic reasons — opens enforcement tools that weren't previously available. The pressure on Mexico to act against cartel leadership has been more sustained and more direct than the Obama or Biden approaches.
The bipartisan applause is real. The problem it was responding to is real. The decline in overdose deaths, however partial and contested, represents actual human lives not lost.
But applause is cheap. The gap between a good State of the Union and a functioning policy regime is filled with budget decisions, regulatory reforms, diplomatic follow-through, and years of unglamorous implementation work. That work doesn't happen in a chamber with cameras. It happens in agency offices where career bureaucrats either execute the policy or slowly suffocate it.
Watch the DEA budget request. Watch the Treasury enforcement actions. Watch whether the cartel FTO designations translate into actual prosecutorial and financial pressure or whether they become talking points without operational teeth. The applause was the easy part.
